These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2291556)

  • 1. Current treatment of Cooley's anemia. Intravenous chelation therapy.
    Cohen AR; Martin M; Schwartz E
    Ann N Y Acad Sci; 1990; 612():286-92. PubMed ID: 2291556
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous chelation therapy with deferoxamine.
    Cohen A; Mizanin J; Schwartz E
    Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
    [No Abstract]   [Full Text] [Related]  

  • 3. Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine.
    Graziano JH; Markenson A; Miller DR; Chang H; Bestak M; Meyers P; Pisciotto P; Rifkind A
    J Pediatr; 1978 Apr; 92(4):648-52. PubMed ID: 633032
    [No Abstract]   [Full Text] [Related]  

  • 4. Current therapy of Cooley's anemia. A decade of experience with subcutaneous desferrioxamine.
    Giardina PJ; Grady RW; Ehlers KH; Burstein S; Graziano JH; Markenson AL; Hilgartner MW
    Ann N Y Acad Sci; 1990; 612():275-85. PubMed ID: 2291555
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacist involvement in a deferoxamine education program for patients with Cooley's anemia.
    Levine HG; Hanan ZI; Gordon FS; Tomasulo WJ
    Am J Hosp Pharm; 1979 Jun; 36(6):788-90. PubMed ID: 463895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy.
    Cohen AR; Mizanin J; Schwartz E
    J Pediatr; 1989 Jul; 115(1):151-5. PubMed ID: 2738783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontransferrin-bound serum iron in thalassemia and sickle cell patients.
    Ahmed NK; Hanna M; Wang W
    Int J Biochem; 1986; 18(10):953-6. PubMed ID: 3792614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vision and hearing during deferoxamine therapy.
    Cohen A; Martin M; Mizanin J; Konkle DF; Schwartz E
    J Pediatr; 1990 Aug; 117(2 Pt 1):326-30. PubMed ID: 2380834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Yersinia infection and hemoglobin disorder. Apropos of 4 cases].
    Pierron H; Gillet R; Perrimond H; Broudeur JC; Soudry G
    Pediatrie; 1990; 45(6):379-82. PubMed ID: 2170907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: a new perspective on Cooley's anemia therapy.
    Ropars C; Teisseire B; Avenard G; Chassaigne M; Hurel C; Girot R; Nicolau C
    Ann N Y Acad Sci; 1985; 445():304-15. PubMed ID: 3860134
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.
    Pippard MJ
    Acta Haematol; 1987; 78(2-3):206-11. PubMed ID: 3120473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of iron overload in Cooley's anemia.
    Cohen A; Mizanin J; Schwartz E
    Ann N Y Acad Sci; 1985; 445():274-81. PubMed ID: 3860130
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term trials of deferiprone in Cooley's anemia.
    Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 1998 Jun; 850():217-22. PubMed ID: 9668542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P; Forte L; Sorrentino F; Palombi M; Papa G; Marciani MG
    Bone Marrow Transplant; 1993; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined subcutaneous and high-dose intravenous deferoxamine therapy of thalassemia.
    Hyman CB; Agness CL; Rodriguez-Funes R; Zednikova M
    Ann N Y Acad Sci; 1985; 445():293-303. PubMed ID: 3860133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of iron chelation therapy.
    Pippard MJ; Callender ST
    Br J Haematol; 1983 Aug; 54(4):503-7. PubMed ID: 6871105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Desferrioxamine B treatment of 4 splenectomized cases of Cooley's anemia].
    Rossi R; Frangini V; Pratesi C
    Riv Clin Pediatr; 1968; 81(5):1002-9. PubMed ID: 5740180
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.
    Vichinsky E; Torres M; Minniti CP; Barrette S; Habr D; Zhang Y; Files B;
    Am J Hematol; 2013 Dec; 88(12):1068-73. PubMed ID: 23946212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):41-7. PubMed ID: 18274982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of treatment with deferoxamine in children with Cooley's disease].
    Taccone F; Monaco L
    Minerva Pediatr; 1967 Dec; 19(50):2255-9. PubMed ID: 5606770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.